U.S. government awards $2.1B to Sanofi-GSK coronavirus vaccine

A researcher works at an industrial development laboratory at the French drugmaker’s vaccine unit Sanofi Pasteur plant in Marcy-l’Etoile, near Lyon, central France, Tuesday, June 16, 2020. | Gonzalo Fuentes/Pool via AP Sanofi and GlaxoSmithKline will receive up to $ 2.1 billion from the U.S. government to further develop their coronavirus vaccine and provide Americans […]

from Newslanes https://ift.tt/3jYd0V9